Indications and uses
Used to reduce skin,pigmentation and fading
Used to reduce skin,pigmentation and fading
1.Apply the product evenly onto clean skin. 2.Massage until fully absorbed. 3.Use daly for several weeks for best results.
Store in a cool, dry place away from direct sunlight and heat. Keep packaging intact.
Glycolic Acid: 3.0%
Kojic Acid: 2.0%
Arbutin: 2.0%
Hydroquinone: 1.0%
Suitable for body whitening,making the skin more even and radiant.
Used to reduce skin,pigmentation and fading
For external use only. Avoid contact with eyes and mucous membranes.
on damaged or broken skin.
For external use only. Avoid contact with eyes and mucous membranes.
Discontinue use ifirritation occurs,
Keep out of reach of children.
1.Apply the product evenly onto clean skin.
2.Massage until fully absorbed.
3.Use daly for several weeks for best results.
Aqua (Water): 70.0%
Glycerin: 5.0%
Cetearyl Alcohol: 3.0%
Stearic Acid: 3.0%
Caprylic/Capric Triglyceride: 10.0%
Phenoxyethanol: 1.0%
Store in a cool, dry place away from direct sunlight and heat.
Keep packaging intact.
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 83872-123 | 83872-123-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| KOJIC ACID | 6K23F1TT52 | ACTIB |
| ARBUTIN | C5INA23HXF | ACTIB |
| GLYCOLIC ACID | 0WT12SX38S | ACTIB |
| HYDROQUINONE | XV74C1N1AE | ACTIB |
| WATER | 059QF0KO0R | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| PHENOXYETHANOL | HIE492ZZ3T | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 36580d9b-50ea-1816-e063-6394a90aed66 | 17774014-620b-a3ca-e063-6394a90a6d78 | 2025-05-30 | Warnings | 17774014-620b-a3ca-e063-6394a90a6d78 |
Adverse event summaries are temporarily unavailable. Other product information remains available.